Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

PURPOSE: The NSABP (National Surgical Adjuvant Breast and Bowel Project) B-24 study demonstrated significant benefit with adjuvant tamoxifen in patients with ductal carcinoma in situ (DCIS) after lumpectomy and radiation. Patients were enrolled without knowledge of hormone receptor status. The curre...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Allred, D. Craig, Anderson, Stewart J., Paik, Soonmyung, Wickerham, D. Lawrence, Nagtegaal, Iris D., Swain, Sandra M., Mamounas, Elefetherios P., Julian, Thomas B., Geyer, Charles E., Costantino, Joseph P., Land, Stephanie R., Wolmark, Norman
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2012
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341142/
https://ncbi.nlm.nih.gov/pubmed/22393101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.34.0141
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky